CLASS II Device recall · Reported 29 Jul 2020 · FDA Enforcement Report

LoFric Origo, Nelaton, FR10 urinary catheters recalled

Wellspect HealthCare (Division of Dentsply IH AB) is recalling LoFric Origo, Nelaton, FR10 urinary catheters, distributed in 22 states. The recall was initiated on 17 Jun 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 447123
Quantity recalledN/A

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2643-2020
FDA event ID
85905
Classification
Class II
Status
Terminated
Recall initiated
17 Jun 2020
FDA classified
17 Jul 2020
Reported
29 Jul 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

17 Jun 2020Recall initiated by company
17 Jul 2020Classified by FDA+30 days
29 Jul 2020Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Wellspect Healthcare is voluntarily recalling certain LoFric¿ Origo" urethral catheters due to a potential defect which may be present in the catheter s distal tip.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

LoFric Origo, Nelaton, 16in, FR10 urinary catheters

Where it was distributed

AL, AZ, CA, CT, FL, GA, IL, IN, KY, MA, MD, MI, MO, NC, NH, NJ, OH, PA, RI, SC, TX, VA and Australia, Brazil, Canada, European Union, China, South Korea, Kuwait, New Zeeland, Singapore, United Kingdom

AlabamaArizonaCaliforniaConnecticutFloridaGeorgiaIllinoisIndianaKentuckyMassachusettsMarylandMichiganMissouriNorth CarolinaNew HampshireNew JerseyOhioPennsylvaniaRhode IslandSouth Carolina

Questions about this recall

Why was it recalled?

Wellspect Healthcare is voluntarily recalling certain LoFric¿ Origo" urethral catheters due to a potential defect which may be present in the catheter s distal tip.

Which lots are affected?

Lot # 447123

Where was it sold?

AL, AZ, CA, CT, FL, GA, IL, IN, KY, MA, MD, MI, MO, NC, NH, NJ, OH, PA, RI, SC, TX, VA and Australia, Brazil, Canada, European Union, China, South Korea, Kuwait, New Zeeland, Singapore, United Kingdom

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 85905

This product is part of a recall event; the main page for the event is LoFric Origo, Tiemann, FR12 urinary catheters recalled.

More recalls from Wellspect HealthCare (Division of Dentsply IH AB)

All 3

Other Heart & Vascular Devices recalls

All 6,199